Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlbion Venture Regulatory News (AAVC)

Share Price Information for Albion Venture (AAVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 43.20
Bid: 42.20
Ask: 44.20
Change: 0.00 (0.00%)
Spread: 2.00 (4.739%)
Open: 43.20
High: 43.20
Low: 43.20
Prev. Close: 43.20
AAVC Live PriceLast checked at -
Albion VCT is an Investment Trust

To manage risk normally associated with investments in smaller, unquoted growth businesses across a variety of sectors including higher risk technology companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Albion Venture Capital Trust PLC: Interim Management Statement

4 Mar 2021 15:10

Albion Venture Capital Trust PLC: Interim Management Statement

ALBION VENTURE CAPITAL TRUST PLCLEI Code: 213800JKELS32V2OK421 Interim Management Statement

Introduction I am pleased to present Albion Venture Capital Trust PLC (the “Company”)’s interim management statement for the period from 1 October 2020 to 31 December 2020.

Performance and dividendsThe Company's unaudited net asset value (NAV) as at 31 December 2020 was £73.7 million or 73.48 pence per share (excluding treasury shares), an increase of 3.89 pence per share (5.6 per cent.) since 30 September 2020. The uplift in NAV is predominantly a result of the sale of the Company’s care home investments after the period end, which are reflected in the 31 December 2020 NAV, and further information on the disposal can be found below.

After accounting for the dividend paid of 1.74 pence per share on 29 January 2021 to shareholders on the register on 8 January 2021, the NAV is 71.74 pence per share.

Portfolio The following investments have been made during the period from 1 October 2020 to 31 December 2020:

New investments£000’sActivity
Seldon Technologies Limited902Software company that enables enterprises to deploy Machine Learning models in production.
uMedeor Limited (T/A uMed)334A middleware technology platform that enables life science organisations to conduct medical research programmes.
Total new investments1,236 

Further investments£000’sActivity
Limitless Technology Limited151Provider of a customer service platform powered by the crowd and machine learning technology.
Arecor Limited69Development of biopharmaceuticals through the application of a formulation technology platform.
Total further investments220 

DisposalsThe following material disposals were made during the period from 1 October 2020 to 31 December 2020:

Portfolio company£000’s 
G. Network Communications Limited1,281Disposal of investment on a cost of £228,000.
Clear Review Limited793Disposal of investment on a cost of £384,000.
Total proceeds2,074 

Top ten holdings (as at 31 December 2020)

InvestmentCarrying value£000’s% of net asset valueActivity
Shinfield Lodge Care Limited14,08819.1%Owner and operator of a 66 bed care home in Shinfield, Berkshire.
Active Lives Care Limited8,71311.8%Owner and operator of a 75 bed care home in Cumnor Hill, Oxfordshire.
Ryefield Court Care Limited7,3289.9%Owner and operator of a 60 bed care home in Hillingdon, Middlesex.
Chonais River Hydro Limited4,2665.8%Owner and operator of a 2 MW hydro-power scheme in the Scottish Highlands.
Radnor House School (TopCo) Limited2,1222.9%Independent school for children aged 3-18.
Gharagain River Hydro Limited1,7842.4%Owner and operator of a 1 MW hydro-power scheme in the Scottish Highlands. 
The Street by Street Solar Programme Limited1,2731.7%Owner and operator of photovoltaic systems on domestic properties in the UK.
Elliptic Enterprises Limited1,2441.7%Provider of Anti Money Laundering services to digital asset institutions.
Cantab Research Limited (T/A Speechmatics)1,1441.6%Provider of low footprint automated speech recognition which can be deployed in the cloud, on premise or on device across 29 languages.
The Evewell (Harley Street) Limited1,0801.5%Operator of a women’s health centre focusing on fertility.

A full breakdown of the Company’s portfolio can be found on the Company’s webpage on the Manager’s website at www.albion.capital/funds/AAVC.

Share buy-backsDuring the period from 1 October 2020 to 31 December 2020, the Company purchased 389,868 Ordinary shares at a cost of £259,000 including stamp duty. All shares are to be held in treasury.

It remains the Board’s policy to buy back shares in the market, subject to the overall constraint that such purchases are in the Company’s interest, including the maintenance of sufficient resources for investment in existing and new portfolio companies and the continued payment of dividends to shareholders.

It is the Board’s intention for such buy-backs to be at around a 5 per cent. discount to net asset value, so far as market conditions and liquidity permit.

Material events and transactions after the period end

Portfolio

After the period end, the Company had the following material investment transaction:

Investment of £1,262,000 in a new portfolio company, Threadneedle Software Holdings Limited (T/A Solidatus), a provider of data lineage software to enterprise customers in regulated sectors, which allows them to rapidly discover, visualise, catalogue and understand how data flows through their systems;Investment of £503,000 in an existing portfolio company, Healios Limited, provider of an online platform delivering family centric psychological care primarily to children and adolescents; andInvestment of £44,000 in an existing portfolio company, ePatient Network Limited (T/A Raremark), provider of an online community connecting people affected by rare diseases.

Care home portfolio disposalThe Board is pleased to announce that, following the period end, the Company completed the sale of its three care homes for the elderly; Active Lives Care Limited, Ryefield Court Care Limited, and Shinfield Lodge Care Limited. The purpose built residential care homes situated across the South of England, offer luxury living with all-inclusive service and an excellent level of care. The homes were trading at mature occupancy levels.

The first investments in the homes were made over 5 years ago and the sale will generate a 2.4x return on cost (including interest received), an excellent result for the Company.

Following the sale, which results in the Company holding significant cash, the Board intends to consider the options available to the Company, including the potential payment of a special dividend, and will provide an update to shareholders in the Annual Report and Financial Statements for the year ended 31 March 2021.

There have been no other significant events or transactions that the Board is aware of which would have a material impact on the financial position of the Company between 1 January 2021 and 4 March 2021.

Further information

The Company continues to offer a dividend reinvestment scheme to existing shareholders. Details of this Scheme can be found at www.albion.capital/funds/AAVC.

Further information regarding historic and current financial performance and other useful shareholder information can be found on the Company’s webpage on the Manager’s website at www.albion.capital/funds/AAVC.

Richard Glover, Chairman4 March 2021

For further information please contact:Albion Capital Group LLP, Company Secretary - Tel: 020 7601 1850

Date   Source Headline
15th Dec 20205:35 pmGNWTransaction in Own Shares and Total Voting Rights and Capital
3rd Dec 202010:35 amGNWAlbion Venture Capital Trust PLC: Half-yearly Financial Report
30th Nov 20201:28 pmGNWTotal voting rights and Capital
30th Oct 20209:34 amGNWTransaction in Own Shares and Capital
30th Sep 20201:44 pmGNWTotal voting rights and Capital
29th Sep 20206:54 pmGNWTransaction in Own Shares and Total Voting Rights and Capital
28th Aug 20208:40 amGNWTotal voting rights and Capital
19th Aug 20205:00 pmGNWAGM Statement
19th Aug 202011:52 amGNWAlbion Venture Capital Trust PLC: Interim Management Statement
14th Aug 20205:00 pmGNWTransaction in Own Shares and Total Voting Rights and Capital
31st Jul 202010:08 amGNWIssue of Equity and Total Voting Rights
13th Jul 20202:15 pmGNWTransaction in Own Shares and Total Voting Rights and Capital
1st Jul 20205:23 pmGNWAlbion Venture Capital Trust PLC: Annual Financial Report
30th Jun 202010:50 amGNWTotal voting rights and Capital
23rd Jun 20204:23 pmGNWDirectorate change
17th Jun 20207:00 amGNWAppointment of Corporate Broker
29th May 202011:45 amRNSTotal voting rights and Capital
30th Apr 20204:40 pmGNWIssue of Equity and Total Voting Rights and Capital
24th Apr 20203:00 pmGNWPublication of a Supplementary Prospectus
22nd Apr 20205:30 pmGNWAlbion Venture Capital Trust PLC: NAV Announcement
21st Apr 20206:32 pmGNWDirectorate change
31st Mar 20204:00 pmGNWTotal voting rights and Capital
18th Mar 20206:00 pmGNWShare buybacks
18th Mar 20203:52 pmGNWTransaction in Own Shares and Total Voting Rights and Capital
18th Mar 20202:30 pmGNWAllotment update
9th Mar 20205:12 pmGNWTransaction in Own Shares and Total Voting Rights and Capital
28th Feb 20204:00 pmGNWTotal voting rights and Capital
28th Feb 202011:26 amGNWTransaction in Own Shares and Total Voting Rights and Capital
21st Feb 202012:10 pmGNWTransaction in Own Shares and Total Voting Rights and Capital
6th Feb 20209:32 amGNWGM Statement - Update
6th Feb 20209:25 amGNWAlbion Venture Capital Trust PLC: Interim Management Statement
6th Feb 20209:18 amGNWDirectorate change
4th Feb 202011:44 amGNWTransaction in Own Shares and Total Voting Rights and Capital
31st Jan 20205:58 pmGNWDirector/PDMR Shareholding
31st Jan 20205:54 pmGNWDirector/PDMR Shareholding
31st Jan 20203:53 pmGNWIssue of Equity and Total Voting Rights and Capital
31st Jan 20208:00 amGNWIssue of Equity and Total Voting Rights
31st Dec 20198:00 amGNWTotal voting rights and Capital
19th Dec 20193:58 pmGNWTransaction in Own Shares and Total Voting Rights and Capital
13th Dec 20199:45 amGNWTransaction in Own Shares and Total Voting Rights and Capital
11th Dec 20193:47 pmGNWCLOSURE OF THE COMPANY’S OFFER UNDER THE ALBION VCTS PROSPECTUS TOP UP OFFERS 2019/20
5th Dec 201912:14 pmGNWTransaction in Own Shares and Total Voting Rights and Capital
4th Dec 20193:36 pmGNWAlbion Venture Capital Trust PLC: Half-yearly Financial Report
29th Nov 20194:00 pmGNWTotal voting rights and Capital
31st Oct 20194:30 pmGNWTotal voting rights and Capital
22nd Oct 20195:07 pmGNWPublication of Prospectus
30th Sep 20193:45 pmGNWTotal voting rights and Capital
30th Sep 201912:50 pmGNWTransaction in Own Shares and Total Voting Rights and Capital
27th Sep 201911:07 amGNWStatement regarding the proposed issue of a prospectus
17th Sep 201910:53 amGNWTransaction in Own Shares and Total Voting Rights and Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.